Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:09 PM
Ignite Modification Date:
2025-12-24 @ 4:09 PM
NCT ID:
NCT03442166
Eligibility Criteria:
Inclusion Criteria:
* Patients who need surgical removal of retained lower third molars;
* Patients who agree to participate in the study after reading and signing the Term of Consent for Participation in Clinical Research.
* Patients with indication for extraction of lower third molars (recurrent infections, bad position, orthodontic indication) or written professional indication (ASA I - negative medical history), systolic blood pressure less than 140mmHg, and diastolic blood pressure lower than 90mmHg and heart rate values of 70 ± 20 beats / minute and have the upper and lower central incisor teeth.
Exclusion Criteria:
* Patients who have systemic diseases, chronic pain or neurological and psychiatric disorders;
* Claim to be smokers;
* Are using anti-inflammatories, analgesics or bisphosphonates in the last 15 days;
* Present active pericoronaritis;
* Are pregnant;
* are breastfeeding;
* Severe temporomandibular disorders
* Have photo sensitivity history
* Are allergic to any drug used in the research (paracetamol, chlorhexidine 2%)
* Patients presenting radiolucent images associated with the teeth to be extracted
* Patients who present any type of complication during surgery (hemorrhage, operative difficulty, time greater than 90 minutes of surgery), as these cases are not in the standard expected for third molar surgeries. In this case the central action analgesic will be prescribed. These data will not be part of the statistical analysis but will be described and discussed as well as possible adverse effects.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
35 Years
Study:
NCT03442166
Study Brief:
Protocol Section:
NCT03442166